{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:50:35Z","timestamp":1791269435864,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-leucine rich glioma inactivated 1 (LGI1) autoimmune encephalitis (AE) is characterized by cognitive impairment or rapid progressive dementia, psychiatric disorders, faciobrachial dystonic seizures (FBDS) and refractory hyponatremia. Since December 2020, millions of people worldwide have been vaccinated against COVID-19. Several soft neurological symptoms like pain, headache, dizziness, or muscle spasms are common and self-limited adverse effects after receiving the COVID-19 vaccine. However, several major neurological complications, despite the unproven causality, have been reported since the introduction of the COVID-19 vaccine. Herein, we describe a 48 years old man presenting with rapidly progressive cognitive decline and hyponatremia diagnosed with anti LGI1 AE, occurring shortly after the second dose of mRNA COVID -19 vaccine and possibly representing a severe adverse event related to the vaccination. Response to high dose steroid therapy was favorable. As millions of people worldwide are currently receiving COVID-19 vaccinations, this case should serve to increase the awareness for possible rare autoimmune reactions following this novel vaccination in general, and particularly of anti-LGI1 AE.<\/jats:p>","DOI":"10.3389\/fimmu.2021.813487","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T07:14:59Z","timestamp":1641366899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination"],"prefix":"10.3389","volume":"12","author":[{"given":"Yair","family":"Zlotnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Gadoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abu-Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Horev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Ifergane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2017.11.004","article-title":"Autoimmune Encephalitis and Psychiatric Disorders","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 Potassium Channel-Complex Proteins Leucine-Rich, Glioma Inactivated 1 Protein and Contactin-Associated Protein-2 in Limbic Encephalitis, Morvan\u2019s Syndrome and Acquired Neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx323","article-title":"The Importance of Early Immunotherapy in Patients With Faciobrachial Dystonic Seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12883-019-1251-4","article-title":"Antibody-LGI 1 Autoimmune Encephalitis Manifesting as Rapidly Progressive Dementia and Hyponatremia: A Case Report and Literature Review","volume":"19","author":"Li","year":"2019","journal-title":"BMC Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies Associated With Diseases of the CNS: New Developments and Future Challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.05.014","article-title":"Neurocardiac Prodrome in LGI1-Antibody-Negative non-Paraneoplastic Limbic Encephalitis","volume":"391","author":"Kaluschke","year":"2018","journal-title":"J Neurol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.10.010","article-title":"Jerking & Confused: Leucine-Rich Glioma Inactivated 1 Receptor Encephalitis","volume":"289","author":"Casault","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 Syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2511","article-title":"Post Vaccination Guillain Barre Syndrome: A Case Report","volume":"10","author":"Wajih Ullah","year":"2018","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.05.002","article-title":"Post-Vaccination Encephalomyelitis: Literature Review and Illustrative Case","volume":"15","author":"Huynh","year":"2008","journal-title":"J Clin Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282x20140064","article-title":"Neurological Complications After H1N1 Influenza Vaccination: Magnetic Resonance Imaging Findings","volume":"72","author":"Lessa","year":"2014","journal-title":"Arquivos Neuro-psiquiatria"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13037-021-00291-9","article-title":"Review the Safety of Covid-19 mRNA Vaccines: A Review","volume":"15","author":"Anand","year":"2021","journal-title":"Patient Saf Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102803","article-title":"Post-COVID-19 Vaccine Acute Hyperactive Encephalopathy With Dramatic Response to Methylprednisolone: A Case Report","volume":"69","author":"Al-Mashdali","year":"2021","journal-title":"Ann Med Surg (2012)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26065","article-title":"ANA Investigates: Neurological Complications of COVID-19 Vaccines","volume":"89","author":"Goss","year":"2021","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ene.15147","article-title":"Neurological Autoimmune Diseases Following Vaccinations Against SARS-CoV-2: A Case Series","author":"Kaulen","year":"2021","journal-title":"Eur J Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26182","article-title":"Postvaccinal Encephalitis After ChAdOx1 Ncov-19","volume":"90","author":"Zuhorn","year":"2021","journal-title":"Ann Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16172","article-title":"Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus","volume":"13","author":"Liu","year":"2021","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577661","article-title":"Hyperacute Reversible Encephalopathy Related to Cytokine Storm Following COVID-19 Vaccine","volume":"358","author":"Baldelli","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B19","first-page":"1000163","article-title":"Vaccines and Neuroinflammation","volume":"3","author":"Giannotta","year":"2018","journal-title":"Int J Pub Heal Safe"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The How\u2019s and What\u2019s of Vaccine Reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100275","article-title":"Encephalopathy in COVID-19 Patients; Viral, Parainfectious, or Both","volume":"21","author":"Umapathi","year":"2020","journal-title":"eNeurologicalSci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.813487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T07:15:01Z","timestamp":1641366901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.813487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2021.813487"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.813487","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"article-number":"813487"}}